 |
Stephen Klasko, M.D. |
 |
Daniel Wilson, M.D., Ph.D. |
 |
Robert Califf, M.D. |
 |
Frederick Meyers, M.D. |
UNMC Chancellor finalist Frederick J. Meyers. M.D., arrives on campus today.
Dr. Meyers, executive associate dean of the School of Medicine at the University of California, Davis, is the first chancellor finalist to visit UNMC; the visit will last until Wednesday.
Dr. Meyers oversees the research, teaching, clinical care and community engagement missions of UC Davis’ School of Medicine in coordination with leadership across the UC Davis community. Dr. Meyers also is the executive director of medical education and academic planning for the University of California, Merced, where he leads efforts to establish a school of medicine.
Dr. Meyers is a proponent of innovative research. He is a director of the Clinical and Translational Science Center’s Research and Education Career Development Program, as well as the Mentored Clinical Research Training Program. He continues research on cancer molecular biology and metastatic cancer, conducting numerous clinical trials on prostate cancer and gene expression in renal cell carcinoma.
Dr. Meyers is a longtime leader of the hospice and palliative care movement, establishing programs that are now national models for providing compassionate end-of-life care. He was founding director of the School of Medicine’s West Coast Center for Palliative Care. He is also known for his work in “simultaneous care,” a model of care that allows cancer patients with advanced disease to receive both investigational treatments and palliative care.
A UC Davis faculty member since 1982, Dr. Meyers is an expert in hematology and oncology, with a special emphasis on the molecular biology of cancer and on clinical trials. His scholarly work includes more than 200 publications, book chapters, editorials and reviews.
Dr. Meyers obtained his medical degree from the UC San Francisco School of Medicine and completed his internship and residency training at UC Davis Medical Center.
Campus visit schedules for the other three finalists will be announced as details become available. The finalists are:
- Robert Califf, M.D., vice chancellor for clinical research and director of the Duke Translational Medicine Institute (DTMI) at the Duke University Medical Center;
- Stephen Klasko, dean of the Morsani College of Medicine and CEO of the Health Sciences Center at the University of South Florida; and
- Daniel Wilson, M.D., Ph.D., dean of the College of Medicine at the University of Florida.